Related references
Note: Only part of the references are listed.Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma
Joseph C. Ahn et al.
HEPATOLOGY (2021)
Biomarkers for Hepatobiliary Cancers
Jean-Charles Nault et al.
HEPATOLOGY (2021)
Advances in resection and transplantation for hepatocellular carcinoma
Eric Vibert et al.
JOURNAL OF HEPATOLOGY (2020)
Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Ming-Da Wang et al.
ONCOLOGIST (2020)
Alpha-fetoprotein response following transarterial chemoembolization indicates improved survival for intermediate-stage hepatocellular carcinoma
Guanghua Liu et al.
HPB (2019)
Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma
J. J. Yu et al.
BRITISH JOURNAL OF SURGERY (2019)
Alpha-fetoprotein for Diagnosis, Prognosis, and Transplant Selection
Franco Trevisani et al.
SEMINARS IN LIVER DISEASE (2019)
Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis
Xiao-Long Li et al.
SURGERY (2019)
Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study
Ming-Da Wang et al.
ONCOLOGIST (2019)
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
Robert Montal et al.
BRITISH JOURNAL OF CANCER (2019)
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Peter R. Galle et al.
LIVER INTERNATIONAL (2019)
Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma A meta-analysis
Chao He et al.
MEDICINE (2019)
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: a multicenter retrospective study
Pei-Yun Zhou et al.
AGING-US (2019)
Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes
Neil Mehta et al.
HEPATOLOGY (2019)
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection
Giovanni Marasco et al.
JOURNAL OF HEPATOLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma A Multicenter Study From China
Xin-Fei Xu et al.
JAMA SURGERY (2019)
Rupture of Hepatocellular Carcinoma: A Review of Literature
Srimanta K. Sahu et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy-an analysis of 1,182 patients in Hong Kong
Miu Yee Chan et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinoma
Masayo Tsukamoto et al.
HEPATOLOGY RESEARCH (2018)
Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines
Carmen Ayuso et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
Xiaoping Wang et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection
Narongsak Rungsakulkij et al.
WORLD JOURNAL OF CLINICAL CASES (2018)
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Masatoshi Kudo et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy
Jun-yi Shen et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma
Mashaal Dhir et al.
ANNALS OF SURGERY (2016)
Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma
S. -L. Yang et al.
BRITISH JOURNAL OF SURGERY (2016)
Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma A Propensity Score Matching Analysis
Tian Yang et al.
JOURNAL OF HEPATOLOGY (2016)
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
Christian Toso et al.
HEPATOLOGY (2015)
On-Treatment Alpha-Fetoprotein Is a Specific Tumor Marker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Entecavir
Grace L. H. Wong et al.
HEPATOLOGY (2014)
Incorporating Biomarkers Into Cancer and Aging Research
Joleen M. Hubbard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The Postresection Alpha-Fetoprotein in Cirrhotic Patients with Hepatocellular Carcinoma. An Independent Predictor of Outcome
Marc-Antoine Allard et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2014)
A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
L. Kadalayil et al.
ANNALS OF ONCOLOGY (2013)
Partial hepatectomy for ruptured hepatocellular carcinoma
T. Yang et al.
BRITISH JOURNAL OF SURGERY (2013)
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy
Wen-jun Ma et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma
A. R. Hakeem et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization
Yan Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Increased Alpha-Fetoprotein Serum Level is Predictive for Survival and Recurrence of Hepatocellular Carcinoma in Non-Cirrhotic Livers
Caroline D. M. Witjes et al.
DIGESTIVE SURGERY (2012)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis
Edoardo G. Giannini et al.
HEPATOLOGY (2012)
Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy
Hidenori Toyoda et al.
JOURNAL OF HEPATOLOGY (2012)
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
Nicola Personeni et al.
JOURNAL OF HEPATOLOGY (2012)
Oncologic Resection for Malignant Tumors of the Liver
Shefali Agrawal et al.
ANNALS OF SURGERY (2011)
Tumor Marker Levels Before and After Curative Treatment of Hepatocellular Carcinoma as Predictors of Patient Survival
Atsushi Nanashima et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Beom Kyung Kim et al.
LIVER INTERNATIONAL (2011)
α-Fetoprotein for Hepatocellular Carcinoma Diagnosis: The Demise of a Brilliant Star
Alejandro Forner et al.
GASTROENTEROLOGY (2009)
New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy
Stephen L. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Unique Localization of Circulating Tumor Cells in Patients With Hepatic Metastases
Long R. Jiao et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
H Imamura et al.
JOURNAL OF HEPATOLOGY (2003)
Share Paper
